Bausch Health Companies Inc has seen a slight uptick this week, despite some volatility in its share price.
Bausch Health Companies Inc (BHC.TO) has experienced a modest increase of 0.15% over the past week, though it faced a decline of 2.31% in today's trading session. As a player in the health care sector, the company's recent developments may be influencing its stock performance. Let's delve into the latest updates and technical indicators surrounding Bausch Health.
Investor takeaway: Investors should remain cautious as Bausch Health continues to navigate a challenging market environment, with recent developments indicating potential growth in specific product areas but overall financial metrics reflecting ongoing struggles.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
Bausch Health Companies Inc
BHC.TO
BHC.TO
Bausch Health Companies Inc
WealthAwesomeMarket cap
$2.53B
52W high
$11.97
52W low
$6.45
1W change
-3.92%
Beta
0.42
Analyst Price Targets
Based on analyst covering BHC
Wall Street analysts forecast BHC stock price to rise 6.0% over the next 12 months.
Consensus
Moderately BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$7.01
+6.0% Upside
Current Price
C$6.61
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BHC's historical volatility
30-Day Vol
45.9%
Annualized
90-Day Vol
41.4%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$5.53
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$6.23 | C$5.32 โ C$7.30 |
| 60 trading days | C$5.87 | C$4.69 โ C$7.34 |
| 90 trading days | C$5.53 | C$4.20 โ C$7.27 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Bausch Health's stock closed at C$6.64, reflecting a year-to-date decline of 31.65%.
With a market cap of approximately C$2.53 billion and a profit margin of -11.5%, Bausch Health is under pressure to improve its financial performance amidst ongoing challenges.
Bull case
The recent listing of PrOKEDI in the RAMQ formulary could improve access for patients and potentially boost sales, which may positively impact Bausch Health's revenue.
Bear case
Despite some positive news, the company's negative profit margin and declining share price year-to-date raise concerns about its financial health and sustainability.
Recent Company News
This week, Bausch Health's Canadian subsidiary announced the listing of PrOKEDI dosages in the RAMQ formulary, marking a significant step as Quรฉbec becomes the first province to include this medication for schizophrenia treatment. This development could enhance access for patients and drive sales growth for the company. Additionally, Bausch Health is set to announce its second-quarter results on July 29, 2026, which could provide further insights into its financial performance.
Technical Picture
Bausch Health's stock closed at C$6.64, sitting within a 52-week range of C$6.45 to C$11.97. The stock is currently trading below both its 50-day moving average of C$7.14 and its 200-day moving average of C$8.19, indicating a bearish trend. The current beta of 0.42 suggests lower volatility compared to the overall market, while the latest trading volume of 174,227 shares is significantly below the 20-day average volume of 523,981 shares, reflecting decreased trading activity.
Market Outlook
Analysts maintain a moderately bullish outlook on Bausch Health, with an average price target of C$7.01, indicating an implied upside of approximately 5.6% from the current price. However, the companyโs financial metrics, including a negative profit margin of -11.5% and an EPS of -4.6, suggest that it has significant hurdles to overcome before achieving sustained growth.
Advertisement
